Finepoint Capital LP acquired a new position in Solid Biosciences Inc. (NASDAQ:SLDB – Get Rating) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 218,562 shares of the company’s stock, valued at approximately $1,176,000. Solid Biosciences makes up approximately 0.4% of Finepoint Capital […]